Back to funds
View filing
venBio Partners LLC
Updated 6 days agoManaged by Venbio Partners Llc • Latest filing Q3 2026
Portfolio value
$495.9M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $216.3M |
| Q1 2026 | $280.6M |
| Q2 2026 | $519.4M |
| Q3 2026 | $495.9M |
Top holdings
9 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $170.1M | 5.27M | 34.29% | — | |
| 2 | $141.4M | 4.46M | 28.52% | — | |
| 3 | ? N/A ATTOVIA THERAPEUTICS INC | $71.7M | 4.18M | 14.45% | — |
| 4 | $47.9M | 5.91M | 9.65% | — | |
| 5 | $31M | 4.19M | 6.25% | — | |
| 6 | $17.9M | 12.88M | 3.61% | — | |
| 7 | $12.5M | 554.8K | 2.52% | — | |
| 8 | $3.3M | 337.7K | 0.67% | — | |
| 9 | ? N/A LISATA THERAPEUTICS INC | $225K | 156.5K | 0.05% | — |